Testing a smartphone app to monitor children with heart disease from home
Tests the MedlyPeds app for remote monitoring in children with heart disease.
Plain-language title generated from the registry record
Registry title: MedlyPeds Feasibility Study
Key facts
- Where
- Toronto, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers with heart disease who are followed at the SickKids cardiology clinic. It tests a smartphone app, MedlyPeds, that monitors them from home.
- Age
- 8 to 18 years
- Sex
- All sexes can join.
- Disease stage
- Followed at the Hospital for Sick Children Cardiology Clinic for heart failure of any cause, congenital heart disease, acquired heart disease (for example Kawasaki disease or rheumatic heart disease), pulmonary hypertension, or after heart surgery (including heart transplant and ventricular assist devices).
Main reasons for not taking part
- Cannot read or write in English
- Taking part in another clinical trial that may affect the results
- Cannot use the Medly app (for example cannot stand on the weight scale or answer symptom questions)
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 18 years old?
Source: NCT07556185, who can take part
Where in Canada
- The Hospital for Sick ChildrenToronto, CanadaContact: Diana Balmer-MinnesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The Hospital for Sick Children
- Trial code
- NCT07556185
- Record updated
- 26 June 2026
- Original description
SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.Read full original descriptionShow less
MedlyPeds Feasibility Study: A Mobile, Smartdevice Based Telemonitoring for Pediatric Heart Disease, a Prospective Cohort Study
SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.
Inclusion: Consent provided; Aged 8-18 years of age; Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.); Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons:; Heart failure of any etiology; Congenital heart disease; Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc); Pulmonary hypertension; Post-cardiac surgery including heart transplant and ventricular assist devices.
Exclusion: Unable to read or write in English; Participating in another clinical trial that may confound the results.* *Participant may be re-screened for eligibility at a later date.